Dr Lalchandani Labs Limited (BOM:541299)
16.71
-0.87 (-4.95%)
At close: Feb 2, 2026
Dr Lalchandani Labs Revenue
Dr Lalchandani Labs had revenue of 20.51M INR in the half year ending September 30, 2025, a decrease of -24.76%. This brings the company's revenue in the last twelve months to 43.80M, up 4.06% year-over-year. In the fiscal year ending March 31, 2025, Dr Lalchandani Labs had annual revenue of 44.54M, down -7.39%.
Revenue (ttm)
43.80M
Revenue Growth
+4.06%
P/S Ratio
1.65
Revenue / Employee
n/a
Employees
18
Market Cap
72.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 44.54M | -3.56M | -7.39% |
| Mar 31, 2024 | 48.10M | -2.31M | -4.58% |
| Mar 31, 2023 | 50.40M | -62.39M | -55.31% |
| Mar 31, 2022 | 112.79M | 14.99M | 15.32% |
| Mar 31, 2021 | 97.80M | 36.76M | 60.23% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 2, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 7.92B |
| One Global Service Provider | 4.45B |
| Chandan Healthcare | 2.57B |
| Star Imaging and Path Lab | 860.99M |
| Modern Diagnostic & Research Centre | 814.48M |
| Invicta Diagnostic | 301.81M |
| Nidan Laboratories and Healthcare | 271.16M |
| Aspira Pathlab & Diagnostics | 242.36M |